MA S1420

Defines psychotropic drugs as those affecting brain activities related to mental processes and behavior, including antipsychotics, antidepressants, anxiolytics, depressants, and potentially anticonvulsants when used for similar purposes

Imposes monetary penalties on nursing homes that fail to submit the required Nursing Home Antipsychotic Medication Measures report to the Centers for Medicare and Medicaid

Allows suspension of new admissions to nursing homes that show a pattern of failure to submit required antipsychotic medication reports

Requires quarterly antipsychotic medication reports to be prominently posted on both the state department website and each nursing home's website as public information

Mandates that care plans for residents receiving psychotropics include the prescriber's name and license number, evaluation date, reasons for prescription, and certified informed consent from the resident or guardian under penalty of perjury